GSK stock jumped back into a buy zone Monday after announcing Chief Executive Emma Walmsley will step down at the end of the year.
GSK (GSK) stock jumped back into a buy zone Monday after announcing Chief Executive Emma Walmsley will step down at the end of the year.
She will be succeeded by Luke Miels, the current chief commercial officer. Prior to joining GSK in 2017, Miels ha... [1620 chars]